Trendlyne Blog: , Latest on stock market and finance in India and the world.

Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets

IND

USA

Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding

Sai Life Science Ltd.

23 Jan 2025, 11:08AM

719.20

-0.39%

Sai Life Sciences Shares Rise After Morgan Stanley Initiates Coverage Here's Why

NDTV Profit

Cost advantage, infrastructure and workforce availability, and global supply chain diversification are driving the growth.

Copy LinkShare on

Share on Share on Share on

Sai Life Science Ltd. has gained 31.00% in the last 6 Months

Akums Drugs & Pharmaceuticals Ltd.

22 Jan 2025, 07:22PM

Board Meeting

566.05

0.38%

Akums Drugs share price down 7% , following IT raid

Business Line

We have fully cooperated with the officials of IT Department during the search and responded to the clarifications and details sought by them, said the company

Copy LinkShare on

Share on Share on Share on

Akums Drugs & Pharmaceuticals Ltd. is trading above all available SMAs

Akums Drugs share plummets 6% after IT Department conducts tax searches

Business Standard | 22 Jan 2025, 01:35PM

Neuland Laboratories Ltd.

22 Jan 2025, 12:01PM

11156.00

-0.33%

Neuland Labs gets capex nod lift; stock up 5% even as broader indices sink

Business Standard

The company said it will spend Rs 254 crore for development and commercial production of Peptides for Generic Drug Substances (GDS) and Custom Manufacturing Solutions (CMS) business.

Copy LinkShare on

Share on Share on Share on

Neuland Laboratories Ltd. has lost -25.15% in the last 6 Months

Neuland Labs Approves Rs 342 Crore Capex To Ehance Capacity Of Two Units

NDTV Profit | 21 Jan 2025

Indoco Remedies Ltd.

22 Jan 2025, 10:47AM

Estimates Miss US FDA Approval

243.61

0.39%

Indoco Remedies Q3 results 2025 on 22 Jan, 2025: loss at 26.39Cr, Revenue decreased by 10.64% YoY

livemint

Indoco Remedies Q3 results 2025 on 22 Jan, 2025: Revenue decreased by 10.64% YoY & loss at 26.39Cr

Copy LinkShare on

Share on Share on Share on

Indoco Remedies Ltd. has an average target of 320.00 from 2 brokers.

Indoco Remedies Q3 Results Review Regulated Market Performance Remains Subdued; Systematix Retains 'Hold'

NDTV Profit | 22 Jan 2025, 09:46AM 2 more

Indoco Remedies Q3 Results: Company Slips Into Loss, Revenue Declines 10.6%

NDTV Profit | 21 Jan 2025

Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY

Business Standard | 21 Jan 2025

Concord Biotech Ltd.

22 Jan 2025, 09:12AM

1535.90

0.25%

Concord Biotech: Citi Reinitiates Coverage With 'Neutral' Amid API Growth Slowdown

NDTV Profit

The API segment sales have experienced a decline of around 9% in financial year 2024 and 3% in first half of financial year 2025E.

Copy LinkShare on

Share on Share on Share on

Concord Biotech Ltd. is trading below all available SMAs

Sequent Scientific Ltd.

21 Jan 2025

179.93

-0.09%

CCI approves amalgamation of multiple pharma entities with Sequent Scientific

Business Line

This strategic move aims to consolidate operations under SSL, a recognised player in the animal healthcare industry, thereby enhancing operational efficiency and fortifying its market position.

Copy LinkShare on

Share on Share on Share on

Sequent Scientific Ltd. has gained 23.05% in the last 1 Month

J B Chemicals & Pharmaceuticals Ltd.

21 Jan 2025

Insider Trades

1702.00

1.02%

KKR to kick off exit process from JB Chemicals in tranches later this year

Business Line

In the first tranche it is likely to sell 20-24 per cent stake worth $650-790 million

Copy LinkShare on

Share on Share on Share on

Number of FII/FPI investors increased from 294 to 319 in Mar 2025 qtr.

Glenmark Pharmaceuticals Ltd.

21 Jan 2025

Board Meeting

1420.20

-0.78%

Glenmark Pharma's US arm launches drug to treat blood clotting issues

Business Standard

According to IQVIA data for the 12-month period ending November 2024, the Vitamin K1 injectable emulsion USP, 10 mg/mL market achieved annual sales of approximately $19.7 million in the US

Copy LinkShare on

Share on Share on Share on

Glenmark Pharmaceuticals Ltd.'s price crossed below 50Day SMA today

Glenmark Pharma Launches Generic Anticoagulant Injectable Emulsion

NDTV Profit | 21 Jan 2025 1 more

Glenmark Pharma share price rises 2% on launching blood clotting drug

Business Standard | 21 Jan 2025

Mankind Pharma Ltd.

21 Jan 2025

Margin Decline

2432.40

-0.28%

Mankind Pharma Share Price Falls After Macquarie Downgrade

NDTV Profit

Mankind's own domestic formulations business has been weak due to slower growth in acute therapies, which accounts for up to 65% of its revenue, Macquarie said.

Copy LinkShare on

Share on Share on Share on

Mankind Pharma Ltd. is trading below its 30 day SMA of 2489.8